Study on Hypoallergenic Hair Dye
NCT04772482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2023-08-25
Summary
Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein, we seek to decrease the risks of allergy to hair dyes by testing a novel version of p-phenylenediamine (PPD) with less allergy potential.
Conditions
- Contact Dermatitis
- Allergy; Dermatitis
- Dermatitis
Interventions
- DIAGNOSTIC_TEST
-
Sensitivity Patch Testing
Testing patches will be applied on the upper arms. Para-phenylene diamine (PPD) 1% will be applied on one upper arm. Para-toluenediamine sulfate (PTD), 2-methoxyethyl p-phenylenediamine (ME-PPD), PPD6 and PPD7 will be applied to the other upper arm.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paul Bigliardi, MD · University of Minnesota
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2022-05-13
- Completion
- 2022-05-13
Countries
- United States
Study Locations
More Related Trials
-
Quaternary Ammonium and Immunization in Hairdressers
NCT05247567 ·Status: TERMINATED ·Phase: NA
-
Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners
NCT03483025 ·Status: COMPLETED ·Phase: NA
-
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
NCT01074840 ·Status: COMPLETED ·Phase: NA
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects
NCT01324843 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
NCT02117752 ·Status: COMPLETED ·Phase: PHASE1
-
Quaternium-15, Use Test
NCT00311454 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Skin Testing Reagents for Penicillin Allergy
NCT01818336 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnosing Drug Allergy: the T is the Key
NCT06409884 ·Status: RECRUITING ·Phase: NA
-
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
NCT00640250 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
NCT00133341 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
NCT04325802 ·Status: WITHDRAWN ·Phase: PHASE2
-
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
NCT00868842 ·Status: COMPLETED
-
Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy
NCT04920721 ·Status: UNKNOWN
-
The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal
NCT03702270 ·Status: COMPLETED ·Phase: NA
-
Cutaneous and Systemic Reactions to Metal Implants
NCT02483728 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis
NCT01125761 ·Status: WITHDRAWN ·Phase: PHASE3
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
NCT00928447 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation
NCT00445029 ·Status: UNKNOWN
-
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
NCT03166241 ·Status: UNKNOWN ·Phase: NA
-
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
NCT03522675 ·Status: COMPLETED ·Phase: NA